RAMP · LiveRamp Holdings, Inc. · Stock research

Current Thesis

RAMP is a merger-arb stub with a dated vote on the calendar. On 2026-05-16 LiveRamp signed a definitive agreement to be acquired by MMS USA Holdings, a Publicis Groupe subsidiary, at $38.50 per share in cash — ~$2.5B equity value, ~$2.167B enterprise value, a ~30% premium to the 2026-05-15 close of ~$29.66. The stock gapped to the cap on the 2026-05-17 announcement and has traded as a spread ever since. Since the last review the process moved forward on schedule: HSR premerger notifications were filed with DOJ and FTC on 2026-06-11, the record date was set at 2026-06-18, and the definitive merger proxy (DEFM14A) now schedules the special meeting for 2026-08-17. At ~$37.82 the gross spread to the contract price is roughly 1.8% into a targeted 2026-12-31 close — about 4% annualized. That is the entire remaining return, and it is not a narrative leg.

Bullish and bearish views on LiveRamp Holdings, Inc.

The model's bull view on LiveRamp Holdings, Inc. (RAMP), in brief: Contract price, not a story, sets the ceiling and the anchor. The bear view: Upside is capped at $38.50 and the market has already taken most of it. Both cases follow in full.

Bull Case

• Contract price, not a story, sets the ceiling and the anchor. $38.50 cash, unanimously board-approved on both sides, no financing condition — the 2026-05-16 agreement replaces price discovery with a number.
• Process is advancing on the stated timetable. HSR filed 2026-06-11; record date 2026-06-18; DEFM14A definitive and mailed, with the vote fixed for 2026-08-17. Nothing in the sequence has slipped since signing.
• Strategic acquirer with a stated integration plan. Publicis guided the deal accretive to headline EPS from year one and will run LiveRamp as an independent business under existing leadership (Scott Howe). Strategics of this size rarely abandon a signed deal absent a regulatory block.
• Both sides are bonded. Reciprocal $32.35M termination fee, outside date 2027-05-16 with a three-month regulatory extension — nine-plus months of runway beyond the target close for CFIUS, foreign antitrust and FDI clearances.
• The standalone business is not distressed. FY2026 revenue $812.9M (+9% YoY), net earnings $146.0M, record operating cash flow $167.8M, ~$379M net cash per the 10-K filed late May 2026. A break would land on real numbers, not a hole.

Bear Case

• Upside is capped at $38.50 and the market has already taken most of it. With the last print near $37.82, roughly $0.68 of headroom remains. Every dollar of the 29.8% premium was paid on 2026-05-17 to whoever owned it the day before.
• Asymmetry is inverted versus anything this playbook trades. A break — CFIUS denial, an antitrust second request that drags past the outside date, or a failed vote — sends the stock toward the ~$29.66 pre-deal base. That is roughly -22% of downside against ~1.8% of upside, about 12:1 against.
• The vote threshold is stricter than it looks. Approval requires 66⅔% of shares outstanding, not of shares voted. Abstentions and unvoted street-name shares function as no votes — the quiet risk in any high-threshold merger vote.
• Three clearances remain unconfirmed. CFIUS, non-US antitrust and FDI approvals had no public sign-off as of mid-July 2026. A French acquirer taking a US identity-graph and consumer-data asset is exactly the profile that draws a national-security look, even if it clears.
• Sell-side has marked the ceiling explicitly. Morgan Stanley raised its target to $38.50 from $33; Craig-Hallum sits at Hold with a $38.50 target. When the consensus target equals the deal price, the research community is stating there is nothing left to model.
• Narrative velocity is zero by construction. No product win, partnership or print lifts a locked cash deal above its contract price. Screener headlines reading the announcement gap as "momentum" are measuring a one-day repricing.

Setup & Price Structure

• Pre-deal base ~$29.66 (2026-05-15 close). Announcement gap to ~$38 on 2026-05-17. That gap is the whole move and it is finished.
• Price has pinned a narrow ~$36–$38.50 band since: $37.42 on 2026-06-05, ~$37.82 mid-July 2026. The band tightens as the vote approaches, which is normal spread compression, not accumulation.
• 52-week range $21.71–$37.91, with the high set post-announcement. Any RSI reading in the 70s here reflects the single gap day, not a trending advance.
• There is no tradable structure: no base to break out of, no moving-average pullback to buy, no measured move. Volatility is event-conditional and one-sided.

Catalyst Calendar (next 30 days)

• 2026-08-17 — Special meeting of stockholders, 11:30am PT, virtual. Vote on adoption of the merger agreement; 66⅔% of outstanding shares required. The one dated, binary event in the window.
• Rolling — CFIUS, non-US antitrust and FDI clearance announcements; timing not publicly scheduled.

Elapsed catalysts

• Late July – mid-August 2026 (est.) — Possible 8-K disclosure of HSR waiting-period expiration or early termination following the 2026-06-11 filing. Absence of news past ~mid-August would itself be information. (passed 59d ago)
• ~2026-08-06 (est.) — ISS/Glass Lewis vote recommendations typically land roughly 10–14 days ahead of a special meeting; a negative recommendation would be the first genuine spread-widening event. (passed 3d ago)
• Not a catalyst: any FY-quarter print. Earnings stopped mattering to price on 2026-05-17. (passed 84d ago)

What Would Change Our Mind

• A topping bid above $38.50. No competing bidder has surfaced in the two months since announcement, and the termination-fee structure discourages one. This would restore an uncapped move but sits at low probability.
• A deal break followed by a fresh standalone base. If antitrust, CFIUS or the vote kills the transaction, the stock resets toward $29–30 on a business doing $812.9M of revenue with ~$379M net cash. Re-evaluation would start only after several weeks of higher lows and a clean breakout structure — not on the break-day panic candle.
• A daily close below $35. That level sits meaningfully below the arb band and would mean the market is repricing completion odds, not merely trimming spread. Everything above it is noise inside a contract.
• A failed or postponed 2026-08-17 vote. Adjournment to solicit more proxies is common and not immediately fatal, but it moves the risk profile from spread-collection to genuine deal risk.

Correlation Notes

• Correlates to merger-arb spread conditions, not to adtech or software factors. RAMP's beta to the Nasdaq is effectively suppressed while the deal stands; it trades against completion probability and the risk-free rate.
• Peer adtech identity and data-collaboration names (TTD, and the retail-media/CDP complex) no longer inform the price. A sector-wide adtech drawdown would not move RAMP materially unless it were severe enough to make Publicis reconsider — a very high bar post-signing.
• The relevant read-across is the M&A regulatory tape: how CFIUS is treating European acquirers of US consumer-data assets, and whether HSR second requests are clustering in adtech. Those set the discount, not LiveRamp's own execution.
• The 2026-06-23 Adobe GenStudio commerce-media integration is evidence the standalone business keeps shipping. It is only relevant in the break scenario, where it strengthens the case for a fresh base rather than a slide back to the old lows.